Top 24 Repertoire Immune Medicines investors
The most complete profiles first. Showing 24 of 24.
Alex GoldsmithVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Avak KahvejianVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more
Verified email available
Ewen CameronVerified
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Katie ElliasVerified
Venture Capital, Investor · United States
SeedAngularJSEducationBiotechnologyElectronic Health Records (EHR)Portfolio: Tetragenetics, Biolinq, Enthera, Provention Bio and 19 more
Verified email available
Molly GibsonVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Nick PlugisVerified
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Sabrina YangVerified
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Sebastian TrousilVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Stephen BerensonVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Torben Straight NissenVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Douglas ColeVerified
Venture Capital, Entrepreneurship Program · United States
Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Ignacio MartinezVerified
Venture Capital, Entrepreneurship Program · United States
Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 52 more
Verified email available
Jim GilbertVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Eytan Weinstein
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Geoffrey von Maltzahn
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Harry Wilcox
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more
Contact details available
Jacob Rubens
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Nathan Stebbins
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Steven St. Peter, M.D.
Venture Capital, Investor · United States
SeedBiotechnologyPharmaceuticalsPortfolio: Tetragenetics, EKR Therapeutics, Biolinq, Enthera and 20 more
Contact details available
Yiqun Bai, Ph.D.
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedEnterprise SoftwareEnergyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Doug ColeVerified
Venture Capital, Angel/Individual, Investor · United States
SeedBiotechnologyPharmaceuticalsPortfolio: Sigilon Therapeutics, Syros Pharmaceuticals, Foghorn Therapeutics, Denali Therapeutics and 1 more
Verified email available
John Casey
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Noubar Afeyan
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Yury Kukushkin
Venture Capital · United States
Portfolio: Tetragenetics, Biolinq, Enthera, Provention Bio and 19 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Repertoire Immune Medicines investors are on Angel Roster?
Angel Roster lists 24 Repertoire Immune Medicines investors. 13 of them (54%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (24), Entrepreneurship Programs (9) and Angel Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Repertoire Immune Medicines investors invest in?
Among those that list a stage, the most common are Series A (14), Seed (3) and Series B (1).
Where are Repertoire Immune Medicines investors based?
Most are based in the United States (24).
Which companies have Repertoire Immune Medicines investors backed?
The most-backed portfolio companies among them are Sigilon Therapeutics (21), Foghorn Therapeutics (21), Denali Therapeutics (21), Syros Pharmaceuticals (21) and Inari (20).
How do I contact Repertoire Immune Medicines investors?
Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.